EURO-NMD is pleased to endorse the 9th meeting in the international series on mitochondrial disease and the search for novel, effective therapies—a key event for those involved in the field of mitochondrial medicine.
Mitochondrial disorders have emerged as a significant cause of inherited human disease. This conference aims to foster collaboration between clinicians, researchers, and industry partners, all working towards the shared goal of developing effective therapies based on a deep understanding of disease mechanisms.
The conference programme is designed to build strong partnerships across disciplines, accelerating the path from discovery to treatment. A dedicated panel session will address current opportunities, challenges, and lessons learned from clinical trials in the field.
This event will bring together international experts and participants working in genomics, biochemistry, pathology, and clinical medicine. It offers a unique platform to highlight the latest advances in basic and translational research while also engaging and inspiring the next generation of scientists.
In addition to keynote talks from global leaders in the field, the conference will feature abstract-selected oral presentations, poster sessions, poster pitch talks, and ample opportunities for networking and collaboration.
EURO-NMD is proud to endorse this important meeting alongside the European Society for Mitochondrial Research and Medicine (E-mit) and the Mitochondrial Medicine Society (MMS).
A draft programme will be available soon.
10–12 November 2025
Wellcome Genome Campus, UK and Virtual